Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 2/20 | 0.49 |
| ▸ | IGF1R | P08069 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CYP26A1 | O43174 | 4/20 | 0.41 |
| ▸ | BCHE | P06276 | 5/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | PRKCI | P41743 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9145294 | 0.84 | SRD5A1 (0.45) | IGF1RALOX15BCHEACHEHSP90AA1 | |
| SCHEMBL5683877 | 0.80 | AKR1B1 (0.51) | AKR1B1ALOX15CYP26A1MAOAMAOB | |
| SCHEMBL22369581 | 0.79 | GRIN2B (0.44) | IGF1RALOX15BCHEACHEGRIN2B | |
| SCHEMBL784291 | 0.76 | MAOB (0.59) | AKR1B1CYP26A1MAOAMAOBPRKCI | |
| SCHEMBL4942353 | 0.76 | PTGS2 (0.54) | ALOX15ACHEALOX5 | |
| SCHEMBL1698287 | 0.76 | PTGS2 (0.41) | BCHEACHEGRIN2B | |
| SCHEMBL3531737 | 0.75 | GAA (0.45) | IGF1RALOX15BCHEACHEALOX5 | |
| SCHEMBL86398 | 0.75 | CASP1 (0.47) | AKR1B1MAOAMAOBPRKCI | |
| SCHEMBL2311686 | 0.74 | GPR84 (0.51) | BCHEMAOA | |
| SCHEMBL19190371 | 0.74 | IGF1R (0.58) | IGF1RALOX15ACHESLC28A3GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103627404-B | Liquid-crystal display | MERCK PATENT GMBH (DE) | 2015-10-28 | — | — | CN | disclosed |
| CN-102439114-B | Liquid crystal display device with a light guide plate | MERCK PATENT GMBH (DE) | 2015-08-26 | — | — | CN | disclosed |
| US-9096795-B2 | Liquid crystal display | MERCK PATENT GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-9096795-B2 | Liquid crystal display | MERCK PATENT GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-9096795-B2 | Liquid crystal display | MERCK PATENT GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| CN-103627404-A | Liquid crystal display | MERCK PATENT GMBH | 2014-03-12 | — | — | CN | disclosed |
| CN-103525430-A | Liquid crystal display | MERCK PATENT GMBH | 2014-01-22 | — | — | CN | disclosed |
| EP-2432851-B1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2013-10-02 | — | — | EP | disclosed |
| EP-2432851-B1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2013-10-02 | — | — | EP | disclosed |
| CN-102439114-A | Liquid crystal display device with a light guide plate | MERCK PATENT GMBH | 2012-05-02 | — | — | CN | disclosed |
| EP-2432851-A1 | LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2012-03-28 | — | — | EP | disclosed |
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-22 | — | — | US | disclosed |
| WO-2010133278-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2010-11-25 | — | — | WO | disclosed |
| WO-2010133278-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2010-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | LPXN, VCL, ACP3 | AKR1B1 3961/4885IGF1R 4526/4885ALOX15 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.